Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.3% | -5.9% | 16.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 82.6% | 84.7% | 78.3% | 75.5% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 0.5% | 6.3% | 0.8% | -2.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17.1% | -15.9% | -13.3% | -9.7% |
| EPS Diluted | -0.46 | -0.44 | -0.38 | -0.24 |
| % Growth | -4.5% | -15.8% | -58.3% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |